Response to Comment on "Type I CD20 Antibodies Recruit the B Cell Receptor for Complement-Dependent Lysis of Malignant B Cells"

J Immunol. 2018 Apr 15;200(8):2517. doi: 10.4049/jimmunol.1800233.

Authors

Patrick J Engelberts^{1

2}, Esther C W Breij¹, T Valerius³, J Schuurman¹, Paul W H I Parren^{4

2}, F J Beurskens¹

Affiliations

¹ Genmab, 3584 CM Utrecht, The Netherlands.
² Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, 2333 ZA Leiden, the Netherlands.
³ Division of Stem Cell Transplantation and Immunotherapy, 2nd Department of Medicine, Christian Albrechts University, 24105 Kiel, Germany.
⁴ Genmab, 3584 CM Utrecht, The Netherlands; [email protected].

PMID: 29632251
DOI: 10.4049/jimmunol.1800233

No abstract available

Publication types

Letter
Comment

MeSH terms

Antigens, CD20*
B-Lymphocytes
Complement System Proteins
Receptors, Antigen, B-Cell*

Substances

Antigens, CD20
Receptors, Antigen, B-Cell
Complement System Proteins